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Abstract
Natural killer (NK) cell activity, lymphokine activated killer (LAK) activity and Epstein-Barr
virus specific cytotoxic T lymphocyte (EBV-CTL) activity were examined in 10 children with
chronic active EB-virus infection and an adult with persistently positive early antigen-antibody
to EB-virus. NK cell activity against erythroleukemia cell line K-562 was significantly (p less
than 0.005) lower in the patients (22.3 +/- 8.5%, mean +/- SD) than in normal controls (40.4 +/-
15.9%). Spontaneous cytotoxicity against an EB-virus transformed autologous lymphoblastoid
cell line was 15.0 +/- 7.6% in the patients, and was comparable to spontaneous cytotoxicity activity
in normal controls (11.7 +/- 4.3%). LAK activity against Raji cells was significantly (p less than
0.02) lower in the patients (14.6 +/- 11.4%) than in normal controls (29.2 +/- 15.9%). EBV-CTL
activity against an EB-virus transformed autologous lymphoblastoid cell line was significantly (p
less than 0.005) lower in the patients (11.8 +/- 5.5%) than in seropositive normal controls (33.7 +/-
14.7%). No regression of the lymphoblastoid cell line was observed when EBV-CTL activity of
the patients was tested by regression assay. It is conceivable that defects in both EB-virus specific
and nonspecific killer cell activities play important roles in the pathogenetic abnormalities which
allow EB-virus infection to progress to a chronic active state.
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